DV Biomed Co., Ltd. (TPEX:6539)

Market Cap	1.17B -15.0%
Revenue (ttm)	794.18M +38.5%
Net Income	7.74M -91.3%
EPS	0.32 -91.4%
Shares Out	24.35M
PE Ratio	145.30
Forward PE	n/a
Dividend	0.60 (1.25%)
Ex-Dividend Date	Jun 17, 2026

Volume	4,617
Average Volume	5,815
Open	46.90
Previous Close	46.90
Day's Range	45.80 - 47.95
52-Week Range	45.75 - 73.81
Beta	0.17
RSI	40.29
Earnings Date	May 13, 2026

About DV Biomed

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Employees: 326
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6539

Financial Performance

In 2025, DV Biomed's revenue was 794.18 million, an increase of 38.46% compared to the previous year's 573.57 million. Earnings were 7.74 million, a decrease of -91.31%.